Jardiance 25mg works through the kidneys by inhibiting sodium-glucose cotransporter 2, or SGLT2. This reduces the reabsorption of filtered glucose and increases the amount of glucose eliminated in urine.

Empagliflozin provides a glucose-lowering mechanism that does not depend directly on increasing insulin secretion. Depending on the patient’s clinical circumstances, SGLT2 inhibitor therapy may also have cardiovascular and kidney-related benefits.

Brand: Jardiance

Active Ingredient: Empagliflozin 25mg

Dosage Form: Tablet

Pack Size: 10 tablets

Drug Class: SGLT2 inhibitor

Route: Oral

Adequate hydration and professional monitoring are important during treatment.